| Therapeutic Metabolomics |
| Monday Track 2 from 10:30 AM - 12:30 PM |
| Chair: Gary Siuzdak Track 2
|
|
|
|
| Mass spectrometry-based metabolomics is used to screen and identify metabolites altered in disease. These alterations are then used as a primary indicator of the enzyme(s) responsible, and the enzymes subsequently targeted with inhibitors for therapeutic benefits. |
|
|
| Email: siuzdak@scripps.edu |
